Viewing nowCombinationUtojet Tablet 10/10mg
Atorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
YuYu Pharmaceutical Co., Ltd.

MFDS item code 202100193 · Approved 2021.01.08 · Insurance code 644503250
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps regulate blood cholesterol and related lipid levels in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial forms, as well as mixed dyslipidemia. It lowers total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol while raising HDL cholesterol levels known as 'good cholesterol', contributing to cardiovascular health improvement. Additionally, this medication is used as an adjunct when non-pharmacological treatments with appropriate dietary management are not sufficiently effective. It's important to identify and treat other secondary causes like diabetes and hypothyroidism before treatment, and regular lipid tests should be conducted during therapy to monitor the condition. This medication is especially effective when there is a high risk of atherosclerotic vascular diseases and is used for the prevention and management of cardiovascular diseases. Therefore, this medication aids in the health management of dyslipidemia patients and improves the risk of cardiovascular diseases.
Administer this medicine once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The recommended initial dose is 10/10 mg or 10/20 mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly.
Serious side effects such as rhabdomyolysis, which can cause severe muscle damage, have been reported for this medication. Therefore, if serious muscle pain or weakness occurs, it should be immediately reported to a doctor. This medication should be temporarily discontinued or stopped in patients with poor kidney function, serious infections, hypotension, or after major surgery. Patients with allergies to any of the components, active liver diseases, pregnant women, women who may become pregnant, and nursing mothers should not use this medication. Patients with muscle disease or those taking Glecaprevir and Pibrentasvir should also refrain from using this medication. Caution is also needed for alcoholics, patients with impaired liver function, patients at risk of certain myopathies, elderly patients, and those taking fibrate class medications. During the course of treatment with this medication, liver function tests and muscle-related tests should be conducted regularly, and if there are liver function abnormalities or worsening muscle pain, it should be discussed with a doctor immediately. This medication has many interactions with other drugs, so dosage adjustment or cessation may be necessary when taken with specific antibiotics, antivirals, cyclosporine, or fibrate class drugs. This medication should not be used during pregnancy or while breastfeeding as it may pose risks to the fetus and baby. Safety in children has not been established; therefore, it is not recommended for children. Elderly individuals should also be cautious due to the increased risk of myopathy. There is no specific antidote for overdose, and treatment should be based on symptoms while monitoring liver function and muscle enzyme levels. It is advised to keep this medication out of reach of children and not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, ideally at room temperature between 1 and 30 degrees. Proper storage will help maintain the medication's effectiveness for a longer period.
White oval film-coated tablets
30 tablets/box [10 tablets/PTP (×3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
YuYu Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.